A Tansu Koparal

Summary

Affiliation: Anadolu University
Country: Turkey

Publications

  1. ncbi request reprint In vitro cytotoxic activities of (+)-usnic acid and (-)-usnic acid on V79, A549, and human lymphocyte cells and their non-genotoxicity on human lymphocytes
    A T Koparal
    Department of Biology, Anadolu University, Eskisehir 26470, Turkey
    Nat Prod Res 20:1300-7. 2006
  2. pmc Effects of Carvacrol on a Human Non-Small Cell Lung Cancer (NSCLC) Cell Line, A549
    A Tansu Koparal
    Department of Biology, Faculty of Science, Anadolu University, 26470, Eskisehir, Turkey
    Cytotechnology 43:149-54. 2003
  3. doi request reprint Angiogenesis inhibition by a lichen compound olivetoric acid
    A Tansu Koparal
    Department of Biology, Faculty of Science, Anadolu University, Eskisehir, Turkey
    Phytother Res 24:754-8. 2010

Detail Information

Publications3

  1. ncbi request reprint In vitro cytotoxic activities of (+)-usnic acid and (-)-usnic acid on V79, A549, and human lymphocyte cells and their non-genotoxicity on human lymphocytes
    A T Koparal
    Department of Biology, Anadolu University, Eskisehir 26470, Turkey
    Nat Prod Res 20:1300-7. 2006
    ..Even low doses of (+)-usnic acid showed high cytotoxic activity against cancerous cells. The MTT results and cell proliferation index (CPI) values based on the CBMN test results are found in good agreement...
  2. pmc Effects of Carvacrol on a Human Non-Small Cell Lung Cancer (NSCLC) Cell Line, A549
    A Tansu Koparal
    Department of Biology, Faculty of Science, Anadolu University, 26470, Eskisehir, Turkey
    Cytotechnology 43:149-54. 2003
    ..The data demonstrate that carvacrol is very potent inhibitor of cell growth in A549 cell line...
  3. doi request reprint Angiogenesis inhibition by a lichen compound olivetoric acid
    A Tansu Koparal
    Department of Biology, Faculty of Science, Anadolu University, Eskisehir, Turkey
    Phytother Res 24:754-8. 2010
    ..These findings suggest that olivetoric acid is a new anti-angiogenic agent and can be developed as a new therapeutic agent for angiogenesis-related diseases...